Short vs long seizure medicine in brain tumor patients
Treatments studied
Part of Brain & nervous system, Cancer clinical trials.
This study compares stopping seizure medicine (levetiracetam) after 6 months versus continuing it longer for people with primary brain tumors. It aims to find out if it is safe to stop the medication sooner and may help you avoid long-term side effects.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older.
- You have had at least one seizure related to your primary brain tumor.
- You have a primary brain tumor that sits above the tentorium (the membrane that separates the top part of the brain from the lower part).
- You have been taking only levetiracetam (Keppra) for seizures and it has been working well for at least 6 months.
- You had brain tumor surgery within the past year and are able to do most of your daily activities on your own (Karnofsky score 50 or higher).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether giving levetiracetam (a seizure-preventing medicine) before and after surgery to remove a brain tumor can reduce the chance of having seizures. It may help patients who have never had a seizure before.
This study tests whether giving a seizure medication (levetiracetam) to people with brain tumors in the movement area can prevent seizures. It compares taking the medication to not taking it, starting before any seizure occurs.
This trial tests whether the drug levetiracetam can prevent seizures in people who have brain tumor surgery. If you are having surgery to remove a brain tumor and have never had a seizure, this study may help keep you from having one after the operation.
This trial studies which seizure medicine works best for adults who recently had their first seizure caused by certain brain tumors. It may help reduce seizures and improve daily functioning while choosing the right medicine after the first episode.
This trial tests whether adding an extended-release seizure medication (levetiracetam) to standard treatment helps people with a certain type of glioblastoma. It may improve outcomes by targeting tumors with low oxygen levels.
This study looks at how a brain tumor-related seizure condition is handled in children and adults. It may be a good option if your seizures started soon after your brain tumor was found or is in the same brain area as your seizure symptoms.
Hear when a new Seizures trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.